8-K 1 cryolife8k012007.txt FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION washington, d.c. 20549 -------------------------------- FORM 8-K -------------------------------- CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): January 29, 2007 _______________________ CRYOLIFE, INC. (Exact name of registrant as specified in its charter) _________________________ Florida 1-13165 59-2417093 (State or Other Jurisdiction (Commission File Number) (IRS Employer of Incorporation) Identification No.) 1655 Roberts Boulevard, N.W., Kennesaw, Georgia 30144 (Address of principal executive office) (zip code) Registrant's telephone number, including area code: (770) 419-3355 _____________________________________________________________ (Former name or former address, if changed since last report) _________________________ Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below): |_| Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |_| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |_| Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |_| Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) -------------------------------------------------------------------------------- Section 5 Corporate Governance and Management Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. (b) On January 29, 2007, the Nominating Committee of the Board of Directors of CryoLife, Inc. (the "Company") was notified by Virginia C. Lacy of her decision not to stand for reelection to the Board of Directors at the Company's Annual Meeting of Stockholders in 2007. Ms. Lacy is expected to continue to serve as a director of the Company until the 2007 Annual Meeting of Stockholders, which is currently expected to be held in May 2007. -2- SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, CryoLife, Inc. has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. CRYOLIFE, INC. Date: January 31, 2007 By: /s/ D.Ashley Lee ----------------------------------- Name: D. Ashley Lee Title: Executive Vice President, Chief Operating Officer and Chief Financial Officer -3-